Sherbrooke Park Advisers »

Ocular Therapeutix shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $85k 19k 4.46

More positions owned by Sherbrooke Park Advisers

Procter & Gamble Company (PG)
Cardinal Health (CAH)
Hologic (HOLX)
Costco Wholesale Corporation (COST)
Motorola Solutions Com New (MSI)
Owens Corning (OC)
Teradata Corporation (TDC)
Marathon Petroleum Corp (MPC)
Johnson & Johnson (JNJ)
Coca-Cola Company (KO)
Starbucks Corporation (SBUX)
Verisk Analytics (VRSK)
Jabil Circuit (JBL)
United Therapeutics Corporation (UTHR)
Molson Coors Beverage CL B (TAP)

View all positions for Sherbrooke Park Advisers

Top funds holding Ocular Therapeutix

VR Adviser
Summer Road
Opaleye Management
Vanguard Group
Franklin Resources
Logos Global Management
Citadel Advisors
Deltec Asset Management
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Banco Santander
Artia Global Partners
D. E. Shaw & Co
Essex Investment Management
Bank of New York Mellon

View all funds holding Ocular Therapeutix